Quick detection of Leishmania in peripheral blood by flow cytometry. Is prestorage leucodepletion necessary for leishmaniasis prevention in endemic areas?
Three years of haemovigilance in a general university hospital
Transfusion for anaemia in the district hospital setting
Used leucodepletion filters as a source of large quantities of DNA suitable for the study of genetic variations in human populations
Establishment of human heterohybridoma and lymphoblastoid cell lines specific for the Rh D and C antigens
Early primary immune response against erythrocytes
National Health Service Litigation Authority claims for ‘wrong blood’ episodes
Conductivity of LISS solutions
Admissions for same day surgery
Responding to the challenge of new and emerging forms of Creutzfeldt-Jakob Disease and Bovine Spongiform Encephalopathy
Living with vCJD – the UK experience
Evaluating the evidence – viral screening
Transfusion associated sepsis – UK SHOT programme
Elimination of pathogens during manufacturing of plasma-derived products
Pathogen inactivation of red cells
Immunohematology in Taiwan
Blood group phenotypes in ethnic groups
Blood groups in our region – what is their clinical significance?
Tracking donor eligibility in the UK
Strategies to predict platelet demand and reduce wastage
Immediate spin compatibility testing – is it as reliable as we think?
Automated interfaced pretransfusion testing and electronic release
Lessons from the UK SHOT programme
Implementing haemovigilance in a major teaching hospital – overcoming the obstacles!
Immunomodulatory effects of Factor IX concentrates in vitro
Cellular fraction of red blood cell concentrates has minimal neutrophil priming activity
The effect on iron stores by polymorphisms in HFE, TfR and DMT1 in blood donors
Reforms to the blood sector – a national approach
Fetal DNA in maternal plasma
Use of 2-D gel electrophoresis to identify proteins accumulating in supernatants of red blood cell products during storage
Recombinant activated factor VIIa for massive haemorrhage in nonhaemophilia patients
Mini dose Rh D immunoglobulin prophylaxis
Transfusion transmitted viral infections – does the ‘precautionary principle’ apply to agents not known to be significant pathogens?
Blood group studies in Taiwan
Genetic, chemical, immunochemical and serological basis of the weak subgroups of ABO
Preparing the patient for surgery without blood transfusion
Haematologist's role
Using pretransfusion samples collected more than 72 h before transfusion. Is it safe?
Blood product request form and specimen labelling errors – the tip of the haemovigilance iceberg?
Monoclonal Anti-PrP, a candidate for detection or treatment of vCJD?
Biological false reactive results
The use of fresh, unrefrigerated whole blood to control massive bleeding – from two centres in western Australia
Policy, regulation and risk
Is zero risk possible?
Risk management
Achieving a balance between risk, cost effectiveness and patient safety. Where to spend?
Why the need for transfusion avoidance?
Evidence based challenges to traditional practice in blood management
Joining forces for the future – how conservation helps the ARCBS
Blood conservation – anaesthetist's pivotal role
Emerging strategies in blood conservation
Blood conservation – perspectives from a regulator
Cord blood expansion
Standards and GMP for haemopoietic stem cell manufacture – approaching a choice
Two years of regulation of the fresh blood sector – a clinical pathologist's perspective
Carbohydrate blood group terminology – are serological concepts enough?
Terminology of red cell surface antigens
The UK approach to understanding donor behaviour
Systems to develop predictive production models
Factor VIII inhibitors in children
Transfusion in neonatal medicine
Intrauterine transfusion
Transfusion Serology Quality Assurance Program 2002